Characterizing the Frequency of Pharmacogenomic Biomarker-Guided Prescribing for Drugs with Pharmacogenomic Biomarker information in the FDA Labelling: A Pilot Study Using Data from an Electronic Health Record.

Emily Beth Devine, Maher Khelifi, Katelyn Keyloun, Nathaniel Hendrix, Patrick Mathias, Christian Bock, Peter Tarczy-Hornoch

Browse the full AMIA paper archive.